Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Substance Withdrawal Syndrome

• Evaluation of the Electronic Cigarette Withdrawal Syndrome
• Pharmacokinetic and Safety Study of Oral Lofexidine in Neonates Experiencing Opioid Withdrawal Due to Intrauterine Exposure to Opioids
• Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
• Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
• Sublingual Dexmedetomidine for Treating Opioid Withdrawal
• Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse
• Evaluating Buspirone to Treat Opioid Withdrawal
• Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit at King Abdullah Specialist Children Hospit
• Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease
• A Study of Oral Ibogaine in Opioid Withdrawal
• Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
• Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal
• Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder
• Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD
• Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal
• Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)
• The Efficacy of N-acetylcysteine Versus Placebo for the Treatment of Metamphetamine Withdrawal Symptoms
• Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome
• Oral Cannabidiol for Opioid Withdrawal
• Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal
• Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
• CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome
• Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal
• Medication Treatment for Opioid Use Disorder in Expectant Mothers
• Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study
• Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study
• Treatment Of Alcohol Withdrawal Syndrome: Dexmedetomidine Vs Diazepam In A Hospital O'horán
• Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine
• The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine
• Efficacy and Safety of Dexmedetomidine During Weaning From Analgesia and Sedation in PICU (TIP-15-01)
• Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure
• Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome
• Varenicline OTC Trial on Efficacy and Safety
• Buspirone for Opioid Tapering
• Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal
• Buprenorphine in the Emergency Department
• MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA)
• Pregabalin for Opiate Withdrawal Syndrome
• Gabapentin for Alcohol Withdrawal Syndrome
• Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction
• Stopping Benzodiazepines and Related Molecules Among Elderly Living in Residential Institutions
• Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED
• Oxytocin Treatment of Opioid Dependence
• Abuse Liability of Pregabalin and Its Effects on Benzodiazepine Withdrawal Symptoms
• A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects
• Open-Label, Safety Study of Lofexidine
• Opioids Withdrawal Syndrome in Critically Ill Patients: a Multicenter Prospective Cohort Study
• Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study
• Safety and Efficacy Study of LUM001 (Maralixibat) With a Drug Withdrawal Period in Participants With Alagille Syndrome (ALGS)
• Electronic Cigarettes in Daily Dependent Smokers
• Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome
• Preventing Alcohol Withdrawal Syndrome With Oral Baclofen
• Clinical Studies on the Therapeutic Effects of Mirtazapine on Drug-craving in Cocaine Addicts.
• Pharmacokinetics of Multiple Dose Methadone in Children Treated for Opiate Withdrawal
• Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal
• Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients
• Oral and IV Baclofen in Adult Volunteers
• Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)
• Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome
• Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
• Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients
• 5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence
• Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
• Effect of the Electronic Cigarette on Withdrawal Symptoms
• Nicotine Replacement Therapy in the Intensive Care Unit
• Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)
• Medications Development for the Treatment of Cannabis Related Disorders
• Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal
• The Effects of One-Time Pregnenolone, Dehydroepiandrosterone (DHEA), or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male Smokers
• Effect of Ondansetron for Withdrawal Symptoms
• Treatment of Marijuana Withdrawal Syndrome Using Escitalopram and Cognitive-Behavior Therapy
• The Effect of Valproate on Benzodiazepine Withdrawal Severity
• Treatment of Polydrug-Using Opiate Dependents During Withdrawal
• Treatment of Alcohol Withdrawal in Hospital Patients
• Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus Lorazepam
• Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome
• Outpatient Treatment of Alcohol Withdrawal Syndrome
• Lithium Cannabis Withdrawal Study
• Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
• Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1
• Effects of Dynorphin 1-13 on Heroin Addiction - 1